Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in persistently active SLE
NCT01753401Phase 4Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in systemic lupus erythematosus (SLE), sponsored by Mallinckrodt Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01753401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753401.